Nanjing Maternal and Child Care Hospital
Nanjing, Jiangsu, 210004, China
NCT Number: NCT00575354
Generally, benign breast tumors are excised under the local anesthesia. But such action was so invasive that every patient would experience the physiological and psychological stimuli unavoidably. Sevoflurane was advised as a better inhalational anesthesic for its "easy come,easy go" property during short-lasting operations than isoflurane. We purposed that sevoflurane would be a superior anesthesic for benign breast tumor excision than isoflurane with relative less alteration in hemodynamics, less postoperative side effects and easily-control the depth of anesthesia.
Looking for future studies?
Notify Me18 year–64 year
Female
Interventional
Phase 4
Nanjing, Jiangsu, 210004, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
3-6% sevoflurane inhaled for anesthesia induction, and 2-3% sevoflurane was used to maintain the anesthesia till the end of the operation.
Other names: Sevofrane
3-6% isoflurane inhaled for anesthesia induction, and 2-3% isoflurane was used to maintain the anesthesia till the end of the operation.
Time frame: 0h to the end of the operation
Time frame: 0h to 24h after the end of the operation
Looking for future studies?
Notify MeNanjing Medical University
Other
Anesthesia With Sevoflurane and Isoflurane for Excision Surgeries in Benign Breast Tumors
Acronym: CSIABTEC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07843121
Behavior, Breast Cancer
Cáceres, Spain
View Trial DetailsNCT00475761
Breast Diseases, Breast Neoplasms
Burlington, Vermont, United States
View Trial DetailsNCT05812040
Breast Diseases, Breast Neoplasms
Guangzhou, Guangdong, China
View Trial DetailsNCT07079436
Anesthesia, Local, Breast Diseases
Shanghai, China
View Trial Details